Jaktinib Hydrochloride Tablets
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Overview
Jaktinib Hydrochloride Tablets is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Jaktinib Hydrochloride Tablets clinical trials
Explore related
Medical disclaimer. This page summarizes research about Jaktinib Hydrochloride Tablets for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.